At a Glance
| Phenylpiracetam | Oxiracetam | |
|---|---|---|
| Class | Stimulants, Nootropic | Stimulants, Nootropic |
| Common Dose (oral) | 100–200 mg | 1200–1800 mg |
| Total Duration | 0.5–1 hrs | 0.5–1.5 hrs |
| Routes | oral | oral |
| Effects | 29 documented | 8 documented |
Phenylpiracetam, a Stimulants, Nootropic, and Oxiracetam, a Stimulants, Nootropic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Stimulants, Nootropics, meaning they share a common pharmacological foundation. They share 7 documented effects in common, with 22 effects unique to Phenylpiracetam and 1 unique to Oxiracetam. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Phenylpiracetam | Oxiracetam | |
|---|---|---|
| Class | Stimulants, Nootropic | Stimulants, Nootropic |
| Common Dose (oral) | 100–200 mg | 1200–1800 mg |
| Total Duration | 0.5–1 hrs | 0.5–1.5 hrs |
| Routes | oral | oral |
| Effects | 29 documented | 8 documented |
| Interaction | Caution | |
| Level | Phenylpiracetam | Oxiracetam |
|---|---|---|
| Threshold | 50 mg | 250 mg |
| Light | 50–100 mg | 500–1200 mg |
| Common | 100–200 mg | 1200–1800 mg |
| Strong | 200–400 mg | 1800–2400 mg |
| Heavy | 400 mg | 2400 mg |
Phenylpiracetam
Oxiracetam
Increased cardiovascular strain and neurotoxicity risk